Get addiction help now: (858) 838-4343

get help now

Get addiction help now: (858) 838-4343

get help now

Tag: ADA

Time to read: 1 min

DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act

April 15, 2022

“The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which prohibits discrimination against people in recovery from opioid use disorder (OUD) who are not engaging in…
Read more

Similar Posts

  • |

    Buprenorphine Information for Physicians

    ByAdmin
    Admin 05/07/2023

    Federal Law Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Read the full text: Public Law 106-310, Sec. 3502. Controlled…

  • |

    Drug Court Fact Sheet

    ByAdmin
    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

  • |

    FOR IMMEDIATE RELEASE

    ByAdmin
    Admin 01/30/2022

    October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become…

  • What is NAMA

    ByAdmin
    Admin 06/14/2023

    NAMA IS COMMITTED TO: Promoting quality methadone maintenance treatment as the most effective modality for the treatment of heroin addiction.  Working to dispel the ignorance regarding MMT which plagues both treatment professionals and the general public.  Fighting discrimination perpetrated against methadone maintenance patients.  Struggling to destigmatize the treatment which has given us back our lives. …

  • Letter

    ByAdmin
    Admin 08/08/2022

    Letter to the editor Clinch Valley News September 15, 2004 Life Center of Galax opened a clinic in Tazewell County (LCG/T) has helped hundreds of people successfully with Methadone treatment, counseling, and group therapy. The people enrolled in the Life Center and the clinic has been met with scrutiny and stigma based on misunderstanding of…

  • About TEXNAMA

    ByAdmin
    Admin 03/17/2022

    Methadone Advocacy: The Time Has Come There are many approaches that a methadone advocacy organization can utilize to bring about change. TexNAMA’s primary objective (as part of NAMA) is the empowerment of patients. By confronting the negative stereotypes TexNAMA works to end the stigma and discrimination that has made recovery and reintegration back into society…